Innovative technology of total parietal peritonectomy for peritoneal carcinomatosis

Abstract

BACKGROUND: Peritonectomy is an integral part of cytoreductive surgery, accompanied by a fairly high incidence of postoperative complications and mortality. In this regard, the improvement and development of easy-to-perform, low-traumatic and safe methods of peritonectomy are topical in oncology.

AIM: Based on experimental studies to develop a technology of pneumodissection of the peritoneum using carbon dioxide insufflation and evaluate its effectiveness.

MATERIALS AND METHODS: The study was conducted on 10 non-embalmed corpses of deceased people whose cause of death is not related to tumors of the abdominal cavity and pelvic organs. The Karl STORZ Thermoflator 26432020-1 Insufflator (FSZ registration certificate 2011/09444, dated 12/21/2017), carbon dioxide cylinders with a volume of 20 liters, silicone lines 1.5 meters long, 1 cm in diameter; Seldinger puncture needle 18 G; flexible polypropylene bougie 16 G were used.

RESULTS: The conducted experimental study made it possible to develop and test a method of total parietal peritonectomy based on the technology of peritoneal pneumodissection using carbon dioxide insufflation. The analysis of the obtained results made it possible to define the concept of a new technology as a method of tissue separation based on the insufflation of carbon dioxide into the connective tissue layers of the retroperitoneal space for the purpose of safe dissection of anatomical structures.

CONCLUSIONS: Peritoneal pneumodissection using gas insufflation is a new and promising technology with a number of obvious advantages. First of all, they include ease of execution, low injury, high safety and, probably, ablasticity, which can potentially create conditions for the prevention of unintentional dissemination of tumor cells in the abdominal cavity. The data obtained as a result of the experimental study allow us to conclude that pneumodissection of the peritoneum using carbon dioxide insufflation is an effective method of performing total parietal peritonectomy and can be used in performing cytoreductive surgical interventions in patients with peritoneal carcinomatosis.

Keywords

cytoreductive surgery / diaphragmatic peritonectomy / gas insufflation / pelvic peritonectomy / peritoneal carcinomatosis / peritonectomy of the lateral walls of the abdomen / pneumodissection / total parietal peritonectomy

References

[1] Sugarbaker PH. Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review. Indian J Surg Oncol. 2019;10(1): 3–23.

[2] Sugarbaker P.H. Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review // Indian J. Surg. Oncol. 2019. Vol. 10, No. 1. P. 3–23.

[3] Spiliotis J, Kopanakis N, Prodromidou A, et al. Peritoneal sarcomatosis: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surg Innov. 2021;28(3):394–395.

[4] Spiliotis J., Kopanakis N., Prodromidou A., et al. Peritoneal sarcomatosis: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy // Surg. Innov. 2021. Vol. 28, No. 3. P. 394–395.

[5] Ganev ShKh, Ganev ShR, Kzyrgalin KR, et al. Peritoneal carcinomatosis in malignant neoplasms of various localizations. Achievements and prospects. Creative surgery and oncology. 2021;11(2): 149–156. (In Russ.)

[6] Ганцев Ш.Х., Ганцев Ш.Р., Кзыргалин К.Р., и др. Перитонеальный канцероматоз при злокачественных новообразованиях различных локализаций. Достижения и перспективы // Креативная хирургия и онкология. 2021. Т. 11, № 2. С. 149–156.

[7] Mercier F, Mohamed F, Cazauran JB, et al. An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy. International Journal of Hyperthermia. 2019;36(1): 744–752.

[8] Mercier F., Mohamed F., Cazauran J.B., et al. An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy // International Journal of Hyperthermia. 2019. Vol. 36, No. 1. P. 744–752.

[9] Arquillière J, Glehen O, Passot G. Cytoreductive surgery in peritoneal carcinomatosis. J Visc Surg. 2021;158(3):258–264.

[10] Arquillière J., Glehen O., Passot G. Cytoreductive surgery in peritoneal carcinomatosis // J. Visc. Surg. 2021. Vol. 158, No. 3. P. 258–264.

[11] Vlasakker V, Lurvink R, Cashin P, et al. The impact of PRODIGE7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases. Eur J Surg Oncol. 2021;47(11): 2888–2892.

[12] Vlasakker V., Lurvink R., Cashin P., et al. The impact of PRODIGE7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases // Eur. J. Surg. Oncol. 2021. Vol. 47, No. 11. P. 2888–2892.

[13] Pakhlevanyan VG, Kolesnikov SA. Electrocoagulation hemostasis, advantages and disadvantages. Actual problems of medicine. 2016;(5(226)):5–9. (In Russ.)

[14] Пахлеванян В.Г., Колесников С.А. Электрокоагуляционный гемостаз, преимущества и недостатки // Актуальные проблемы медицины. 2016. № 5 (226). С. 5–9.

[15] Solovyov IA, Gaivoronsky IV, Korytova LI, et al. Clinical and anatomical substantiation of pelvic peritoneum plasty in multivisceral resections and extended operations in patients with locally advanced cancer of the pelvic organs. Bulletin of the National Medical and Surgical Center. N.I. Pirogov. 2015;10(1):35–44. (In Russ.)

[16] Cоловьев И.А., Гайворонский И.В., Корытова Л.И., и др. Клинико-анатомическое обоснование пластики тазовой брюшины при мультивисцеральных резекциях и расширенных операциях у больных местнораспространенным раком органов малого таза // Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2015. Т. 10, № 1. С. 35–44.

[17] Turov FO, Yatsyk SP, Poddubnyi IV, et al. The advantage of using modern methods of intraoperative hemostasis in laparoscopic operations on the organs of the genitourinary system in children. Reproductive health of children and adolescents. 2018;(2):47–54. DOI: 10.24411/1816-2134-2018-12005

[18] Туров Ф.О., Яцык С.П., Поддубный И.В., и др. Преимущество применения современных методов интраоперационного гемостаза при лапароскопических операциях на органах мочеполовой системы у детей // Репродуктивное здоровье детей и подростков. 2018. № 2. С. 47–54. DOI: 10.24411/1816-2134-2018-12005

[19] Farrell R. Peritonectomy and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer: What gynaecological oncologists really think. Aust N Z J Obstet Gynaecol. 2019;59(3):457–462.

[20] Farrell R. Peritonectomy and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer: What gynaecological oncologists really think // Aust. N. Z. J. Obstet. Gynaecol. 2019. Vol. 59, No. 3. P. 457–462.

[21] Khatib G, Guzel AB, Gulec UK, et al. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer. Gynecol Oncol. 2017;146(3):674–675.

[22] Khatib G., Guzel A.B., Gulec U.K., et al. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer // Gynecol. Oncol. 2017. Vol. 146, No. 3. P. 674–675.

RIGHTS & PERMISSIONS

Prosvetov V.A., Surov D.A., Gaivoronsky I.V., Nguyen V.